…py to enhance and restore response to immunotherapy in advanced solid tumors.Trial Registration Clinically, our study includes patients recr…
Solid Malignancies
This disease is selected. Its supporting articles are shown below.
Articles mentioning Solid Malignancies
8 articles · page 1 of 1…DFS/PFS presented R² 0.39 across all RCTs (51 ICs), and 0.65 in NSCLC (21 ICs; p<0.01).Conclusions Early use of anti-PD-(L)1 therapy …
…only underlie resistance to immune checkpoint blockade (ICB) in solid malignancies. Novel combination therapies may overcome these barriers, provi…
…AR0602 in combination with HDAC inhibitors for the treatment of solid malignancies including those resistant to current ICB therapies.…
…oadjuvant settings for a number of solid malignancies including cutaneous melanoma as compared with adjuvant schemes. A key difference between bot…
…tat, in different ICB-refractory murine tumor models, including CT26 (colorectal) and MOC-1 (HPV16 neg head and neck).Methods Mice r…
…ent (TME) impose substantial barriers to cancer treatment. Many solid malignancies create a hyperosmotic TME due to increased interstitial fluid p…
…n. These results offer great hope to patients with a variety of solid malignancies because those who experience complete clinical responses may be…